Bayer (OTCPK:BAYRY) started the week up 3.5% to €74/share in Frankfurt, touching their highest level in 14 months, after the U.S. government said a $25M glyphosate decision against the company should be reversed.
Both the EPA and DOJ wrote in a friend of the court brief that a federal appeals court should reverse a lower court verdict finding the company liable in the case of a man who blamed Bayer’s Roundup for his cancer.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.